Northern Patent of the Month

//Northern Patent of the Month

Northern Ireland Patent of the Month – May 2025

By |June 19th, 2025|

GreenLab, Inc. has developed a plant-powered breakthrough to fight pollution. U.S. Patent Application No. 20250161732, titled ‘Compositions and methods for degradation of pollutants by plant-produced manganese peroxidase’, outlines a system that uses corn to produce a powerful cleanup enzyme.

Read More

Northern Ireland Patent of the Month – April 2025

By |June 19th, 2025|

A novel approach to cancer immunotherapy has emerged with the development of Mi-2β inhibitors, designed to counteract tumor resistance to immune checkpoint blockade therapies. This innovation is detailed in U.S. Patent No. 12,268,674, titled “Mi-2β inhibitor as an immunotherapy agent,” assigned to BioVentures, LLC. (patents.justia.com)

Read More
#SRscotland

Quick Contact

News & Research

Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms

June 2025 brought major legislative changes for Texas businesses, with new laws that both supercharge research and development (R&D) incentives and ease burdens for small businesses. These reforms underscore Texas’s commitment to remaining a business-friendly state while fostering innovation and entrepreneurship.

Enhanced Franchise Tax Credit for R&D

Governor Greg Abbott signed Senate Bill 2206 into law on June 17, 2025. The bill significantly strengthens the R&D franchise tax credit, increasing the rate from 5% to 8.722% for qualifying research expenses. The changes will take effect for franchise tax reports due on or after January 1, 2026.

This legislation also aligns Texas’s credit with federal R&D definitions, allowing businesses to reference IRS Form 6765 and supporting methodologies. Importantly, the credit is now permanent, removing its previous expiration date in 2026.

While the credit becomes more generous, it comes with a trade-off. The bill repeals the sales and use tax exemption for certain R&D-related property, effective January 1, 2026. Businesses will need to evaluate which benefit provides greater value under their specific circumstances.

Streamlining for Small Businesses

Also on June 17, Governor Abbott signed several bills designed to reduce barriers for small business owners. These include House Bills 346, 2464, and 5195, which together modernize filing systems, remove unnecessary regulation, and improve state digital services.

  • HB 346 enables expedited business filings and makes permanent the exemption from franchise taxes and fees for veteran-owned businesses.
  • HB 2464 limits the ability of cities to impose new regulations on certain home-based businesses.
  • HB 5195 directs state agencies to modernize their online platforms for improved access to business services.

Governor Abbott emphasized that small businesses account for nearly half of the state’s workforce and play a critical role in Texas’s economic success. These changes aim to remove obstacles that prevent entrepreneurs from growing and thriving.

Fort Worth Named Aviation and Defense Capital

In a symbolic move reinforcing the state’s support for regional innovation, Senate Concurrent Resolution 142 officially designates Fort Worth as the “aviation and defense capital of Texas.” This strengthens the city’s position as a national center for advanced manufacturing and aerospace development.

Next Steps for Business Leaders

With these new laws taking effect in 2026, companies should begin preparing now:

  • Review your R&D expenditures and consider transitioning to the enhanced franchise tax credit.
  • Confirm that your R&D documentation aligns with federal standards to ensure eligibility and audit readiness.
  • Take advantage of new filing options and tax relief programs-especially for veteran-owned and home-based businesses.
  • Watch for updates from state agencies as they modernize their online services under HB 5195.

These legislative changes send a clear signal: Texas intends to remain a top destination for innovation and small business success.

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Read more
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – May 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Read more
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – April 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Read more

Please call: 1-800-986-4725
or have Swanson Reed call you.

Privacy and Complaint Policy

Copyright Notice ©

Wales Patent of the Month – May 2025

Alleviant Medical Inc. has secured U.S. Patent No. 12290305 for its ‘Transcatheter device for interatrial anastomosis’, a breakthrough in treating heart failure without permanent implants. The new device offers a minimally invasive solution for pressure relief in the heart’s upper chambers, potentially transforming care for millions of patients.

Implant-Free Innovation for Heart Failure

This device uses radiofrequency energy to create a precise hole in the heart’s septum, establishing a controlled left-to-right atrial shunt. Unlike other methods, it avoids leaving any implant behind, which may lower complication risks and improve long-term outcomes. The goal is to reduce elevated left atrial pressure, a key issue in heart failure with preserved or reduced ejection fraction.

Regulatory Momentum and Trial Readiness

The technology has earned Breakthrough Device designation from the FDA. Alleviant is preparing for pivotal trials, including the ALLAY-HFrEF study, to evaluate safety and efficacy in symptomatic patients who have not responded to conventional treatments.

Potential for Widespread Impact

Heart failure remains a leading cause of hospitalization. This solution offers new hope for patients seeking effective therapy without added surgical burden. If clinical success follows, this could mark a significant shift in interventional cardiology.

 

Learn More:

Are you developing new or improved products, or thinking of applying for a patent? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.

Feel free to book a quick teleconference with one of R&D Tax specialists if you would like to learn more about R&D Tax Credit opportunities.

Who We Are:

Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years.

Swanson Reed’s Texas office provides R&D tax credit consulting and advisory services to Houston, San Antonio, Dallas, Austin, Fort Worth, El Paso, Arlington, Corpus Christi, Plano, Laredo, Lubbock, Garland, Irving, Amarillo, Grand Prairie, Brownsville, McKinney, Frisco, Pasadena, and Mesquite.

Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs. For more information please click here or contact your usual Swanson Reed representative.

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Read more
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – May 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Read more
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – April 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Read more

Please call: 1-800-986-4725
or have Swanson Reed call you.

Privacy and Complaint Policy

Copyright Notice ©